Clinical Trial Update: Teverelix Evaluated in Advanced Prostate Cancer [Phase 2]

View source ↗

Summary

Antev Ltd. reports Phase 2 results update for Teverelix in advanced prostate cancer, with results posted on July 23, 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Teverelix (teverelix)

Snippet

Sponsor: Antev Ltd. | Conditions: Prostatic Adenoma | Phase 2 | Status: COMPLETED | Results posted: 2024-07-23